报价延迟最少15分钟:2026/08/25 10:46 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.6 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.88/0.04
|
|
企业价值
701.63M
|
| 资产负债 |
|
每股账面净值
4.13
|
| 现金流量 |
|
现金流量率
0.00
|
| 损益表 |
|
收益
292.50M
|
|
每股收益
8.13
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's productofferings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA. |
